Gut-Liver Interactions: From IBD to NASH
Falk Symposium 201, Innsbruck (Austria), March 2016
nor-UDCA put to the test:
“We believe that this could
be a breakthrough in the
treatment of PSC”
To better understand the pathophysiological link between intestinal and
hepatic disorders and to derive therapeutic advantage from this insight – this was the central objective of the International Symposium 201 of the Falk Foundation e.V. in Innsbruck. The focus was on bile acids as effective therapeutic strategies in inflammatory and immunological gastrointestinal and hepatic disorders. More...